ATE358726T1 - Virus hüllprotein-rezeptorchimäre und deren verwendungen - Google Patents

Virus hüllprotein-rezeptorchimäre und deren verwendungen

Info

Publication number
ATE358726T1
ATE358726T1 AT00968759T AT00968759T ATE358726T1 AT E358726 T1 ATE358726 T1 AT E358726T1 AT 00968759 T AT00968759 T AT 00968759T AT 00968759 T AT00968759 T AT 00968759T AT E358726 T1 ATE358726 T1 AT E358726T1
Authority
AT
Austria
Prior art keywords
receptor
virus
virus envelope
envelope protein
chimeric
Prior art date
Application number
AT00968759T
Other languages
English (en)
Inventor
Anthony Louis Devico
Timothy R Fouts
Robert G Tuskan
Original Assignee
Univ Maryland Biotech Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland Biotech Inst filed Critical Univ Maryland Biotech Inst
Application granted granted Critical
Publication of ATE358726T1 publication Critical patent/ATE358726T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00968759T 1999-10-08 2000-10-06 Virus hüllprotein-rezeptorchimäre und deren verwendungen ATE358726T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15832199P 1999-10-08 1999-10-08

Publications (1)

Publication Number Publication Date
ATE358726T1 true ATE358726T1 (de) 2007-04-15

Family

ID=22567583

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00968759T ATE358726T1 (de) 1999-10-08 2000-10-06 Virus hüllprotein-rezeptorchimäre und deren verwendungen

Country Status (9)

Country Link
EP (1) EP1137786B1 (de)
AT (1) ATE358726T1 (de)
AU (1) AU7862500A (de)
CY (1) CY1106691T1 (de)
DE (1) DE60034211T2 (de)
DK (1) DK1137786T3 (de)
ES (1) ES2284532T3 (de)
PT (1) PT1137786E (de)
WO (1) WO2001027294A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040076636A1 (en) * 1993-05-07 2004-04-22 Ranajit Pal HIV immunogenic complexes
US6908612B2 (en) * 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
AU2003301556A1 (en) * 2002-05-07 2004-05-13 Chiron Corporation Hiv envelope-cd4 complexes and hybrids
US20040171565A1 (en) * 2003-02-14 2004-09-02 David Hone DNA vaccines that expresses mutant ADP-ribosyltransferase toxins which display reduced, or are devoid of, ADP-ribosyltransferase activity
WO2008118926A1 (en) * 2007-03-26 2008-10-02 University Of Maryland Biotechnology Institute A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof
WO2014055413A2 (en) * 2012-10-02 2014-04-10 Bloodcenter Research Foundation A method of providing cellular therapy using modified natural killer cells or t lymphocytes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT89484B (pt) * 1988-01-22 1994-03-31 Gen Hospital Corp Genes clonados codificadores de proteinas de fusao ig-cd4 e sua utilizacao
WO1992005799A1 (en) * 1990-09-28 1992-04-16 Hospital For Joint Diseases Method for inhibiting the infectivity of human immunodeficiency virus
EP0652764B1 (de) * 1992-02-10 2000-05-24 Duke University Verwendung synthetischer peptide zur induktion der toleranz gegen t- und b-zell epitope von autoantigenen
DK0699077T3 (da) * 1993-05-07 2002-01-21 Bio Merieux Inc Immunogele HIV-komplekser
AU7127798A (en) * 1997-04-18 1998-11-13 President And Fellows Of Harvard College Bifunctional polypeptides for cell-specific viral targeting

Also Published As

Publication number Publication date
CY1106691T1 (el) 2012-05-23
PT1137786E (pt) 2007-07-13
DK1137786T3 (da) 2007-08-06
DE60034211D1 (de) 2007-05-16
AU7862500A (en) 2001-04-23
DE60034211T2 (de) 2007-12-20
WO2001027294A9 (en) 2002-05-16
EP1137786B1 (de) 2007-04-04
EP1137786A1 (de) 2001-10-04
ES2284532T3 (es) 2007-11-16
WO2001027294A1 (en) 2001-04-19

Similar Documents

Publication Publication Date Title
WO2003016333A3 (en) Virus coat protein/receptor chimeras and methods of use
Chanh et al. Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response
AU3401289A (en) Endowing cells with antibody specificity
EP1035210A3 (de) Von SIVagm abgeleitete lentivirale Vektoren, Verfahren zu ihrer Herstellung und ihre Verwendung zur Genübertragung in Säugerzellen
KR910004207A (ko) 치료기능을 가진 알부민 유도체
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
CA2395291A1 (en) Five-helix protein
WO1998009642A3 (en) Therapeutic chemokine antagonists
AU3762889A (en) Hiv-3 retrovirus and its use
Follis et al. Genetic evidence that interhelical packing interactions in the gp41 core are critical for transition of the human immunodeficiency virus type 1 envelope glycoprotein to the fusion-active state
CY1106691T1 (el) Πρωτεϊνη του καψιδιου ιου/χιμαιρες υποδοχεα και μεθοδοι χρησης
EP2305818A3 (de) Antigen-Konstrukte, für den Nachweis und die Unterscheidung von Antikörpern gegen HIV
DK0975783T3 (da) Retrovirusvektorer, fremgangsmåde til fremstilling heraf samt deres anvendelse til genoverføring til CD4-positive celler
EP3725319A1 (de) Verfahren und zusammensetzungen zur behandlung von hiv
WO2001016182A3 (en) POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE
WO2007024976A3 (en) Virus coat protein/receptor chimeras and methods of use
Chen et al. HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41
WO2000049038A3 (de) Synthetische peptide des regulatorischen virusproteins r (vpr) des humanen immundefizienzvirus typ 1 (hiv-1) und ihre verwendung
WO2002069691A3 (en) Immunogenic hiv peptides for use as reagents and vaccines
Mehrotra et al. Immunomodulation by peptide analogs of retroviral envelope protein
WO1994006921B1 (en) Recombinant retroviral vector against felv and/or fiv
Marques HIV-1 Rev C-terminal domain is important for Rev function restriction in murine A9 cells (Immune deficiency)
Wachinger et al. The p17 stretch at the N terminus of the HIV1-gag precursor and the intracellular part of HIV1-env gp41 have heptad repeat regions in their sequences that could bind to each other in a coiled coil
Xiao et al. HIV-1 gp41 and type I interferon
AU6794698A (en) Strl33, a human fusion accessory factor associated with hiv infection

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1137786

Country of ref document: EP